A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder.

MLA

Tsiplova, Kate, et al. “A Microcosting and Cost-Consequence Analysis of Clinical Genomic Testing Strategies in Autism Spectrum Disorder.” Genetics in Medicine : Official Journal of the American College of Medical Genetics, vol. 19, no. 11, Nov. 2017, pp. 1268–75. EBSCOhost, https://doi.org/10.1038/gim.2017.47.

APA

Tsiplova, K., Zur, R. M., Marshall, C. R., Stavropoulos, D. J., Pereira, S. L., Merico, D., Young, E. J., Sung, W. W. L., Scherer, S. W., & Ungar, W. J. (2017). A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder. Genetics in Medicine : Official Journal of the American College of Medical Genetics, 19(11), 1268–1275. https://doi.org/10.1038/gim.2017.47

Chicago

Tsiplova, Kate, Richard M Zur, Christian R Marshall, Dimitri J Stavropoulos, Sergio L Pereira, Daniele Merico, Edwin J Young, Wilson W L Sung, Stephen W Scherer, and Wendy J Ungar. 2017. “A Microcosting and Cost-Consequence Analysis of Clinical Genomic Testing Strategies in Autism Spectrum Disorder.” Genetics in Medicine : Official Journal of the American College of Medical Genetics 19 (11): 1268–75. doi:10.1038/gim.2017.47.